You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
4 May 2026 - Norwegian bladder cancer company Photocure ASA (OSE: PHO) announced on Monday the publication of a new health economic methodology in The Journal of Medical Economics demonstrating that blue light cystoscopy is cost-effective compared wi...
4 May 2026 - Apotex Inc, a Canada-based global health company, announced on Friday that Health Canada has approved Apo-Semaglutide InjectionTM, a generic equivalent of Ozempic (semaglutide injection).Apotex is the first Canada-based pharmaceutical co...
4 May 2026 - Spinogenix Inc, a California-based clinical-stage biopharmaceutical company announced on Sunday that it will present the results of two new preclinical studies demonstrating the neuroprotective effects of tazbentetol (SPG302) in glaucoma...
4 May 2026 - Australia-based independent biopharmaceutical company Specialised Therapeutics (ST) announced on Sunday that its NIKTIMVO (axatilimab) has been approved for use in Australia by the Therapeutic Goods Administration (TGA) for the treatment...
1 May 2026 - Australian pharmaceutical company Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) announced on Thursday that the marketing authorisation application (MAA) filed in Europe for TLX101-Px (O-(2-[18F] fluoroethyl)-L-tyrosine, 18F-FET),...
1 May 2026 - FDB (First Databank Inc), a provider of workflow-integrated drug knowledge for healthcare professionals, announced on Thursday the launch of its new gravimetric module, designed to help pharmacies improve the safety, accuracy, and effici...
1 May 2026 - Bioregenerative technology company FesariusTherapeutics Inc announced on Thursday the publication of its peer reviewed evidence of category leading speed of 'neodermis' formation, which it claims may have the potential to reduc...